Chinese drugmaker Puyunhui questions SAMR's inconsistency in penalty decision at court
Weifang Puyunhui Pharmaceutical, a Chinese supplier of raw materials for pharmaceutical products, has argued at a Beijing court that the country's competition regulator showed inconsistency in its penalty decision against the...To view the full article, register now.
Already a subscriber? Click here to view full article